Market Research Logo

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018, Forecast to 2023

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018, Forecast to 2023

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.

Scope of the Report:
This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for ICAD (Intracranial Atherosclerotic Disease) Pathology is expected to grow at a CAGR of roughly 8.7% over the next five years, will reach 220 million US$ in 2023, from 130 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Stryker
Balt
TERUMO
MicroPort
Acandis

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
primarily split into
Stent
PTA Balloon

Market Segment by Applications, can be divided into
Hospital
Clinic
Other

There are 15 Chapters to deeply display the global ICAD (Intracranial Atherosclerotic Disease) Pathology market.
Chapter 1, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, with sales, revenue, and price of ICAD (Intracranial Atherosclerotic Disease) Pathology, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of ICAD (Intracranial Atherosclerotic Disease) Pathology, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, ICAD (Intracranial Atherosclerotic Disease) Pathology market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe ICAD (Intracranial Atherosclerotic Disease) Pathology sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Introduction
1.2 Market Analysis by Type
1.2.1 primarily split into
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Stryker
2.1.1 Business Overview
2.1.1.1 Stryker Description
2.1.1.2 Stryker Headquarter, Main Business and Finance Overview
2.1.2 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.1.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.1.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.2 Balt
2.2.1 Business Overview
2.2.1.1 Balt Description
2.2.1.2 Balt Headquarter, Main Business and Finance Overview
2.2.2 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.2.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.2.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.3 TERUMO
2.3.1 Business Overview
2.3.1.1 TERUMO Description
2.3.1.2 TERUMO Headquarter, Main Business and Finance Overview
2.3.2 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.3.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.3.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.4 MicroPort
2.4.1 Business Overview
2.4.1.1 MicroPort Description
2.4.1.2 MicroPort Headquarter, Main Business and Finance Overview
2.4.2 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.4.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.4.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
2.5 Acandis
2.5.1 Business Overview
2.5.1.1 Acandis Description
2.5.1.2 Acandis Headquarter, Main Business and Finance Overview
2.5.2 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
2.5.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
2.5.2.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Information
2.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in 2017
3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition, by Manufacturer
3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Manufacturer (2016-2017)
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer Market Share in 2017
3.4.2 Top 5 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Analysis by Regions
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Regions
4.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions (2013-2018)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions (2013-2018)
4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.5 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2013-2018)
5 North America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
5.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
5.1.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
5.1.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
5.1.3 United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
5.1.4 Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
5.1.5 Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
5.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
5.2.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
5.3 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
5.3.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
5.4 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
5.4.2 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
6 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
6.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
6.1.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
6.1.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
6.1.3 Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.4 UK ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.5 France ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.6 Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.1.7 Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
6.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
6.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
6.3 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
6.3.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
6.4 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
6.4.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
7.1.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
7.1.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.4 Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.5 Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.6 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
8 South America ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
8.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
8.1.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
8.1.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
8.1.3 Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
8.1.4 Argentina ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
8.1.5 Colombia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
8.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
8.2.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
8.3 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
8.3.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
8.4 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
8.4.2 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
9.1.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.4 UAE ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.5 Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.6 Nigeria ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.1.7 South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Revenue Share by Application (2013-2018)
10 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Type
10.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Market Share by Type (2013-2018)
10.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Market Share by Type (2013-2018)
10.2 primarily split into Sales Growth and Price
10.2.1 Global primarily split into Sales Growth (2013-2018)
10.2.2 Global primarily split into Price (2013-2018)
10.3 Stent Sales Growth and Price
10.3.1 Global Stent Sales Growth (2013-2018)
10.3.2 Global Stent Price (2013-2018)
10.4 PTA Balloon Sales Growth and Price
10.4.1 Global PTA Balloon Sales Growth (2013-2018)
10.4.2 Global PTA Balloon Price (2013-2018)
11 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Application
11.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Growth Rate (2018-2023)
12.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Regions (2018-2023)
12.2.1 North America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.2 Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.3 Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.4 South America ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.2.5 Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast (2018-2023)
12.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Type (2018-2023)
12.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Type (2018-2023)
12.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Type (2018-2023)
12.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Forecast by Application (2018-2023)
12.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Forecast by Application (2018-2023)
12.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Picture
Table Product Specifications of ICAD (Intracranial Atherosclerotic Disease) Pathology
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of ICAD (Intracranial Atherosclerotic Disease) Pathology by Types in 2017
Figure primarily split into Picture
Table Major Manufacturers of primarily split into
Figure Stent Picture
Table Major Manufacturers of Stent
Figure PTA Balloon Picture
Table Major Manufacturers of PTA Balloon
Figure ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Figure United States ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Germany ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure France ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure UK ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Russia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Italy ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure China ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (Value) and Growth Rate (2013-2023)
Table Stryker Headquarter, Established, Main Business and Finance Overview (2017)
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table Balt Headquarter, Established, Main Business and Finance Overview (2017)
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table TERUMO Headquarter, Established, Main Business and Finance Overview (2017)
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table MicroPort Headquarter, Established, Main Business and Finance Overview (2017)
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table Acandis Headquarter, Established, Main Business and Finance Overview (2017)
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Production Bases, Sales Regions and Major Competitors
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
Table Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in 2017
Figure Global Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer (2016-2017)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer in 2016
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Manufacturer in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturer (2016-2017)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturer in 2016
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Manufacturer in 2017
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2016-2017)
Figure Top 3 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer (Revenue) Market Share in 2017
Figure Top 6 ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturer (Revenue) Market Share in 2017
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Regions (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Regions (2013-2018)
Table Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Regions (2013-2018)
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions in 2013
Figure Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Regions in 2017
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Asia-Pacific ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure South America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure South America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Growth Rate (2013-2018)
Figure Middle East and Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue and Growth Rate (2013-2018)
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Countries (2013-2018)
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries in 2013
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share by Countries in 2017
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Countries (2013-2018)
Table North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries (2013-2018)
Figure North America ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Market Share by Countries in 2013

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report